Susan M. Huang‡, Tiziana Bisogno§, Timothy J. Petros‡, Sai Y. Chang , Paul A. Zavitsanos**,
Robert E. Zipkin‡‡, Ramachandran Sivakumar‡‡, Andrew Coop§§, Dean Y. Maeda§§,
Luciano De Petrocellis¶, Sumner Burstein¶¶, Vincenzo Di Marzo§, and J. Michael Walker‡

From the ‡Departments of Psychology and Neuroscience, Brown University, Providence, Rhode Island 02912, §Istituto per
la Chimica di Molecole di Interesse Biologico and ¶Istituto di Cibernetica-Consiglio Nazionale delle Ricerche,
Endocannabinoid Research Group, Via Toiano 6, 80072 Arco Felice, Napoli, Italy, Applied Biosystems, Framingham,
Massachusetts 01701, **Agilent Technologies, Wilmington, Delaware 19808, ‡‡BIOMOL Research Laboratories Inc.,
Plymouth Meeting, Pennsylvania 19462, §§Department of Pharmaceutical Sciences, University of Maryland School of
Pharmacy, Baltimore, Maryland 21201, and ¶¶Department of Biochemistry and Molecular Pharmacology, University of
Massachusetts Medical School, Worcester, Massachusetts 01655
